Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Quetiapine Treatment for Symptoms Associated With Borderline Personality Disorder

This study has been completed.
Sponsor:
Collaborator:
AstraZeneca
Information provided by:
Rutgers, The State University of New Jersey
ClinicalTrials.gov Identifier:
NCT00122070
First received: July 15, 2005
Last updated: June 9, 2008
Last verified: June 2008
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: May 2008
  Primary Completion Date: September 2007 (Final data collection date for primary outcome measure)